Use of a portable infrared 3D scanning device measuring limb volume in a safety net hospital breast clinic

2021 ◽  
Author(s):  
Bernadette N. White ◽  
Joel Okoli ◽  
J. Brandon Dixon ◽  
Liu Yuan ◽  
Steven Yang ◽  
...  
Keyword(s):  
Safety Net ◽  
3D Scanning ◽  
Limb Volume ◽  
Breast Clinic ◽  
Scanning Device ◽  
Safety Net Hospital

scholarly journals An infrared 3D scanning device as a novel limb volume measurement tool in breast cancer patients

2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Bernadette N. White ◽  
Iris M. Lu ◽  
LeslieAnn S. Kao ◽  
J. Brandon Dixon ◽  
Michael J. Weiler ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Survivors ◽  
Volume Measurement ◽  
3D Scanning ◽  
Small Sample ◽  
Measurement Tool ◽  
Breast Cancer Patients ◽  
Limb Volume ◽  
Scanning Device ◽  
Tape Measure

Abstract Background Lymphedema is a common complication of breast cancer treatment that affects one in five breast cancer survivors, yet there is no reliable method to detect lymphedema in the subclinical range. The objective of this study was to determine the feasibility and reliability of using an infrared 3D scanning device (ISD) as a peri-operative limb volume measurement tool. Methods Fifteen patients were analyzed based on inclusion criteria. Peri-operative measurements were obtained using tape measure and an ISD. Volumes were calculated using a standard algorithm for tape measure and a custom algorithm for ISD measurements. Linear regression models were used to assess ISD and tape measurement volume and circumference correlation. One-way ANOVA was used to compare change in percent difference at set time points post-operatively (2–3 weeks, 4–6 weeks, and 7–12 weeks) for both ISD and tape measure. t tests for unequal variances with the Bonferroni correction were performed among these groups. Results There is a positive linear correlation (R2 = 0.8518) between absolute volume measurements by the ISD and tape measure. Analyses over 2–10 weeks post-operatively showed that the ISD was able to detect volume changes in both the unaffected and the affected arm. Furthermore, the affected arm tended to have a greater increase in volume in the majority of patients, indicating these patients could be at risk for lymphedema. Conclusions Technology utilizing infrared 3D scanners can reliably measure limb volume pre- and post-treatment similarly to tape measure in a small sample of patients. Further research using 3D scanning technology with a longer follow up is warranted.

scholarly journals An Infrared 3D Scanning Device as a Novel Limb Volume Measurement Tool in Breast Cancer Patients

2020 ◽  
Author(s):  
Bernadette N White ◽  
Iris M Lu ◽  
LeslieAnn S Kao ◽  
Brandon J Dixon ◽  
Michael J Weiler ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Large Scale ◽  
Breast Cancer Survivors ◽  
Volume Measurement ◽  
3D Scanning ◽  
Small Sample ◽  
Measurement Tool ◽  
Limb Volume ◽  
Scanning Device ◽  
Tape Measure

Abstract Background Lymphedema is a common complication of breast cancer treatment that affects one in five breast cancer survivors yet there is no reliable method to detect lymphedema in the subclinical range. The objective of this study was to determine the feasibility and reliability of using an infrared 3D scanning device (ISD) as a peri-operative limb volume measurement tool.Methods Fifteen patients were analyzed based on inclusion criteria. Peri-operative measurements were obtained using tape measure and an ISD. Volumes were calculated using a standard algorithm for tape measure and a custom algorithm for ISD measurements. Linear regression models were used to assess ISD and tape measurement volume and circumference correlation. One-way ANOVA was used to compare change in percent difference at set time points post-operatively (2–3 weeks, 4–6 weeks, and 7–12 weeks) for both ISD and tape measure. T-Tests for unequal variances with the Bonferroni correction were performed among these groups.Results There is a positive linear correlation (R-squared = 0.8518) between absolute volume measurements by the ISD and tape measure. Analyses over 2–10 weeks post-operatively showed that the ISD was able to detect volume changes in both the unaffected and the affected arm. Furthermore, the affected arm tended to have a greater increase in volume in the majority of patients, indicating these patients could be at risk for lymphedema.Conclusions Technology utilizing infrared 3D scanners can reliably measure limb volume pre and post treatment similarly to tape measure in a small sample of patients. Further large-scale studies are needed to validate this method in a diverse population.

scholarly journals An Infrared 3D Scanning Device as a Novel Limb Volume Measurement Tool in Breast Cancer Patients

2020 ◽  
Author(s):  
Bernadette N White ◽  
Iris M Lu ◽  
LeslieAnn S Kao ◽  
Brandon J Dixon ◽  
Michael J Weiler ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Survivors ◽  
Volume Measurement ◽  
3D Scanning ◽  
Small Sample ◽  
Measurement Tool ◽  
Breast Cancer Patients ◽  
Limb Volume ◽  
Scanning Device ◽  
Tape Measure

Abstract Background Lymphedema is a common complication of breast cancer treatment that affects one in five breast cancer survivors yet there is no reliable method to detect lymphedema in the subclinical range. The objective of this study was to determine the feasibility and reliability of using an infrared 3D scanning device (ISD) as a peri-operative limb volume measurement tool.Methods Fifteen patients were analyzed based on inclusion criteria. Peri-operative measurements were obtained using tape measure and an ISD. Volumes were calculated using a standard algorithm for tape measure and a custom algorithm for ISD measurements. Linear regression models were used to assess ISD and tape measurement volume and circumference correlation. One-way ANOVA was used to compare change in percent difference at set time points post-operatively (2-3 weeks, 4-6 weeks, and 7-12 weeks) for both ISD and tape measure. T-Tests for unequal variances with the Bonferroni correction were performed among these groups.Results There is a positive linear correlation (R-squared = 0.8518) between absolute volume measurements by the ISD and tape measure. Analyses over 2-10 weeks post-operatively showed that the ISD was able to detect volume changes in both the unaffected and the affected arm. Furthermore, the affected arm tended to have a greater increase in volume in the majority of patients, indicating these patients could be at risk for lymphedema. Conclusions Technology utilizing infrared 3D scanners can reliably measure limb volume pre and post treatment similarly to tape measure in a small sample of patients. Further research using 3D scanning technology with a longer follow up is warranted.

1195-P: Improving Diabetes Self-Management with a Mobile App: Results of a Pilot Program at a Safety Net Hospital System

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1195-P
Author(s):  
ROOPA KALYANARAMAN MARCELLO ◽  
JOHANNA DOLLE ◽  
SHARANJIT KAUR ◽  
SAWKIA R. PATTERSON ◽  
NICHOLA DAVIS
Keyword(s):  
Safety Net ◽  
Mobile App ◽  
Self Management ◽  
Pilot Program ◽  
Hospital System ◽  
Safety Net Hospital

scholarly journals COVID-19 Pandemic and the Cholecystitis Experience at a Major Urban Safety-Net Hospital

2021 ◽  
Vol 264 ◽  
pp. 117-123
Author(s):  
Katherine F Vallès ◽  
Miriam Y Neufeld ◽  
Elisa Caron ◽  
Sabrina E Sanchez ◽  
Tejal S Brahmbhatt
Keyword(s):  
Safety Net ◽  
Safety Net Hospital ◽  
Urban Safety

Patient Capability, Confidence, and Interest in Telemedicine at a Public Safety Net Hospital Urology Clinic

2021 ◽  
Vol 32 (2) ◽  
pp. 1047-1058
Author(s):  
Andin Josipovic ◽  
Jeffrey Reese ◽  
Erin C. Cantarero ◽  
Christopher S. Elliott
Keyword(s):  
Public Safety ◽  
Safety Net ◽  
Safety Net Hospital ◽  
Urology Clinic

scholarly journals Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

2020 ◽  
Vol 5 (3) ◽  
Author(s):  
Ravi J. Chokshi ◽  
Jin K. Kim ◽  
Jimmy Patel ◽  
Joseph B. Oliver ◽  
Omar Mahmoud
Keyword(s):  
Overall Survival ◽  
Neoadjuvant Chemotherapy ◽  
Abdominal Wall ◽  
Intraperitoneal Chemotherapy ◽  
Hyperthermic Intraperitoneal Chemotherapy ◽  
Safety Net ◽  
Insurance Status ◽  
Gynecologic Malignancies ◽  
Safety Net Hospital ◽  
The Impact

AbstractObjectivesThe impact of insurance status on oncological outcome in patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is poorly understood.MethodsRetrospective study on 31 patients having undergone 36 CRS-HIPEC at a single institution (safety-net hospital) between 2012 and 2018. Patients were categorized as insured or underinsured. Demographics and perioperative events were compared. Primary outcome was overall survival (OS).ResultsA total of 20 patients were underinsured and 11 were insured. There were less gynecologic malignancies in the underinsured (p=0.02). On univariate analysis, factors linked to poor survival included gastrointestinal (p=0.01) and gynecologic malignancies (p=0.046), treatment with neoadjuvant chemotherapy (p=0.03), CC1 (p=0.02), abdominal wall resection (p=0.01) and Clavien–Dindo 3-4 (p=0.01). Treatment with neoadjuvant chemotherapy and abdominal wall resections, but not insurance status, were independently associated with OS (p=0.01, p=0.02 respectively). However, at the end of follow-up, six patients were alive in the insured group vs. zero in the underinsured group.ConclusionsIn this small, exploratory study, there was no statistical difference in OS between insured and underinsured patients after CRS-HIPEC. However, long-term survivors were observed only in the insured group.

Evaluation of Patterns in Access to Breast Cancer Care and Breast Cancer Presentation in a Safety Net Patient Population

2021 ◽  
pp. 000313482096628
Author(s):  
Erica Choe ◽  
Hayoung Park ◽  
Ma’at Hembrick ◽  
Christine Dauphine ◽  
Junko Ozao-Choy
Keyword(s):  
Breast Cancer ◽  
Cancer Screening ◽  
Breast Cancer Screening ◽  
Cancer Care ◽  
Patient Population ◽  
Safety Net ◽  
Minority Women ◽  
Breast Cancer Care ◽  
Safety Net Hospital ◽  
Screening Mammograms

Background While prior studies have shown the apparent health disparities in breast cancer diagnosis and treatment, there is a gap in knowledge with respect to access to breast cancer care among minority women. Methods We performed a retrospective analysis of patients with newly diagnosed breast cancer from 2014 to 2016 to evaluate how patients presented and accessed cancer care services in our urban safety net hospital. Patient demographics, cancer stage, history of breast cancer screening, and process of referral to cancer care were collected and analyzed. Results Of the 202 patients identified, 61 (30%) patients were younger than the age of 50 and 75 (63%) were of racial minority background. Only 39% of patients with a new breast cancer were diagnosed on screening mammogram. Women younger than the age of 50 ( P < .001) and minority women ( P < .001) were significantly less likely to have had any prior screening mammograms. Furthermore, in patients who met the screening guideline age, more than half did not have prior screening mammograms. Discussion Future research should explore how to improve breast cancer screening rates within our county patient population and the potential need for revision of screening guidelines for minority patients.

Sign in / Sign up

Export Citation Format

Share Document